Concord Biotech Limited, Founded in 1984, is a research-driven biopharmaceutical company headquartered in India. Renowned globally, it stands as a leading developer and producer of fermentation-based APIs in immunosuppressants and oncology. Its market presence in 2022, measured by volume, is notable.
With a widespread global footprint, Concord Biotech serves over 70 countries, including the USA, India, Europe, and Japan. The company specializes in manufacturing Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, it has evolved into a versatile solution provider.
Concord’s product range encompasses fermentation and semi-synthetic offerings in therapeutic categories like Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and more. This diverse portfolio has attracted a broad clientele worldwide. Additionally, the company boasts a promising pipeline of products currently in development.
Concord Biotech IPO Details #
Concord Biotech IPO is a Book Built Issue. The IPO total issue size is Rs 1,551.00 Cr. The Concord Biotech IPO price is ₹705 to ₹741 per share. The IPO will list on BSE, NSE.
| IPO Date | Aug 4, 2023 to Aug 8, 2023 |
| Listing Date | [.] |
| Face Value | ₹1 per share |
| Price | ₹705 to ₹741 per share |
| Lot Size | 20 Shares |
| Total Issue Size | 20,925,652 shares (aggregating up to ₹1,551.00 Cr) |
| Offer for Sale | 20,925,652 shares of ₹1 (aggregating up to ₹1,551.00 Cr) |
| Employee Discount | Rs 70 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 104,616,204 |
| Share holding post issue | 104,616,204 |
Concord Biotech IPO Reservation #
Concord Biotech IPO a total of 20,925,652 shares are offered. QIB: 4,183,130 (19.99%), RII: 7,320,479 (34.98%), NII: 3,137,348 (14.99%).
| Anchor Investor Shares Offered | 6,274,695 (29.99%) |
| QIB Shares Offered | 4,183,130 (19.99%) |
| NII (HNI) Shares Offered | 3,137,348 (14.99%) |
| Retail Shares Offered | 7,320,479 (34.98%) |
| Employee Shares Offered | 10,000 (0.05%) |
| Total Shares Offered | 20,925,652 (100%) |
Concord Biotech IPO Anchor Investors Details #
Concord Biotech IPO raises Rs 464.95 crore from anchor investors. Concord Biotech IPO Anchor bid date is Aug 3, 2023. Concord Biotech IPO Anchor Investors list
| Bid Date | Aug 3, 2023 |
| Shares Offered | 6,274,695 |
| Anchor Portion Size (In Cr.) | 464.95 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sep 26, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Dec 26, 2023 |
Concord Biotech IPO Timetable (Tentative) #
Concord Biotech IPO opens on Aug 4, 2023, and closes on Aug 8, 2023.
| IPO Open Date | Friday, 4 August 2023 |
| IPO Close Date | Tuesday, 8 August 2023 |
| Basis of Allotment | Friday, 11 August 2023 |
| Initiation of Refunds | Monday, 14 August 2023 |
| Credit of Shares to Demat | Thursday, 17 August 2023 |
| Listing Date | Friday, 18 August 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Aug 8, 2023 |
Concord Biotech IPO Lot Size #
The minimum lot size of this Concord Biotech IPO is 20 shares required is ₹14,820.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,820 |
| Retail (Max) | 13 | 260 | ₹192,660 |
| S-HNI (Min) | 14 | 280 | ₹207,480 |
| S-HNI (Max) | 67 | 1,340 | ₹992,940 |
| B-HNI (Min) | 68 | 1,360 | ₹1,007,760 |
| Lot Size Calculator | |||
Concord Biotech IPO Promoter Holding #
Sudhir Vaid and Ankur Vaid are the Company Promoters.
| Pre Issue Share Holding | 44.08% |
| Post Issue Share Holding | 44.08% |
Company Financials #
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 1,182.55 | 1,312.80 | 1,513.98 |
| Revenue | 630.75 | 736.35 | 888.48 |
| Profit After Tax | 234.89 | 174.93 | 240.08 |
| Net Worth | 999.37 | 1,103.22 | 1,290.00 |
| Reserves and Surplus | |||
| Total Borrowing | 86.35 | 60.59 | 31.24 |
Key Performance Indicator #
Concord Biotech IPO Market Cap is Rs 7752.06 Cr and P/E (x) is 32.29.
| KPI | Values |
|---|---|
| P/E (x) | 32.29 |
| Market Cap (₹ Cr.) | 7752.06 |
| ROE | 20.06% |
| ROCE | 24.27% |
| EPS (Rs) | 20.79 |
| RoNW | 20% |
Objects of the Issue #
The objectives of the Offer are to:
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
- Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
Concord Biotech IPO Subscription Status (Bidding Detail) #
The Concord Biotech IPO is subscribed 24.87 times on Aug 8, 2023 7:02:00 PM. The public issue subscribed 3.78 times in the retail category, 67.67 times in the QIB category, and 16.99 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 67.67 |
| NII | 16.99 |
| bNII (bids above ₹10L) | 19.30 |
| sNII (bids below ₹10L) | 12.37 |
| Retail | 3.78 |
| Employee | 24.48 |
| Total | 24.87 |
Total Application : 1,264,369 (3.45 times)
Concord Biotech IPO Prospectus #
- › Concord Biotech IPO DRHP
- › Concord Biotech IPO RHP
- › Anchor Investors in Concord Biotech IPO
Company Contact Information #
1482-86,
Trasad Road Dholka,
Ahmedabad – 382225
Phone: 079-6813 8700
Email: complianceofficer@concordbiotech.com
Website: http://www.concordbiotech.com/
Concord Biotech IPO Registrar #
Phone: +91-22-4918 6270
Email: concordbiotech.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
